Hans Edgar Bishop is CEO & President at Juno Therapeutics, Inc. (JUNO). They have made 8 open-market trades across 1 company since 2015, most recently 2026-07-06.
CIK 0001480212
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JUNO | SELL | 2018-01-16 | 2018-01-18 | $46.17 | $25.0M | +22.8% | +21.7% | N/A |
| JUNO | SELL | 2016-09-27 | 2016-09-29 | $33.00 | $1.5M | -3.7% | -19.3% | -36.8% |
| JUNO | SELL | 2016-09-19 | 2016-09-21 | $30.29 | $4.9M | -5.6% | -9.8% | -39.4% |
| JUNO | SELL | 2016-09-08 | 2016-09-09 | $30.06 | $1.4M | +11.9% | +7.4% | -33.0% |
| JUNO | SELL | 2016-08-31 | 2016-09-02 | $30.06 | $2.6M | +1.1% | +3.6% | -30.8% |
| JUNO | SELL | 2016-06-30 | 2016-09-02 | $38.45 | $8.9M | +1.1% | +3.6% | -30.8% |
| JUNO | SELL | 2016-06-09 | 2016-06-13 | $46.72 | $5.7M | +6.1% | -26.2% | -28.6% |
| JUNO | SELL | 2016-02-29 | 2016-03-02 | $35.32 | $6.4M | -5.7% | -9.2% | +1.9% |
| JUNO | SELL · 10b5-1 | 2015-12-15 | 2015-12-17 | $45.72 | $4.2M | -18.7% | -26.3% | -14.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.